Inmaculada Nacher-Jimenez

La Paz, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Incorporation of patient-reported outcomes into pharmacy and dermatology departments, in psoriasis and atopic dermatitis patients, as a tool to improve the healthcare quality and health outcomes

Incorporation of patient-reported outcomes into pharmacy and dermatology departments, in psoriasis and atopic dermatitis patients, as a tool to improve the healthcare quality and health outcomes

Journal: Journal of healthcare quality research

Published: October 03, 2022

The role of the pharmacist within an immune-mediated inflammatory disease unit: Results of a survey of healthcare providers and patients.

The role of the pharmacist within an immune-mediated inflammatory disease unit: Results of a survey of healthcare providers and patients.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: November 22, 2021

Real-World Experience with Two-Drug Regimens in HIV-1-Infected Patients Beyond the Indication of Clinical Trials: 48 Weeks' Results.

Real-World Experience with Two-Drug Regimens in HIV-1-Infected Patients Beyond the Indication of Clinical Trials: 48 Weeks' Results.

Journal: AIDS research and human retroviruses

Published: September 01, 2021

Inhaled bronchodilators use and clinical course of adult inpatients with Covid-19 pneumonia in Spain: A retrospective cohort study.

Inhaled bronchodilators use and clinical course of adult inpatients with Covid-19 pneumonia in Spain: A retrospective cohort study.

Journal: Pulmonary pharmacology & therapeutics

Published: July 23, 2020

Real-world experience of palbociclib and ribociclib: novel oral therapy in metastatic breast cancer.

Real-world experience of palbociclib and ribociclib: novel oral therapy in metastatic breast cancer.

Journal: International journal of clinical pharmacy

Published: July 09, 2020

Cost evolution of biological drugs in rheumatoid arthritis patients in a tertiary hospital: Influential factors on price.

Cost evolution of biological drugs in rheumatoid arthritis patients in a tertiary hospital: Influential factors on price.

Journal: Reumatologia clinica

Published: May 14, 2019

Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients.

Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: January 10, 2019

Effect of mono/dual antiretroviral therapy on suppression of HCV and HIV during treatment of HCV infection in HIV/HCV-coinfected patients.

Effect of mono/dual antiretroviral therapy on suppression of HCV and HIV during treatment of HCV infection in HIV/HCV-coinfected patients.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: June 12, 2018

Cost evolution of biological agents for the treatment of spondyloarthritis in a tertiary hospital: influential factors in price.

Cost evolution of biological agents for the treatment of spondyloarthritis in a tertiary hospital: influential factors in price.

Journal: International journal of clinical pharmacy

Published: December 26, 2017

Analysis of antiretroviral therapy modification in routine clinical practice in the management of HIV infection.

Analysis of antiretroviral therapy modification in routine clinical practice in the management of HIV infection.

Journal: European journal of hospital pharmacy : science and practice

Published: March 28, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026